Revolution Medicines, Inc. - Common Stock (RVMD)
CUSIP: 76155X100
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,966,469
- Total 13F shares
- 73,332,089
- Share change
- -1,948,000
- Total reported value
- $1,845,795,329
- Put/Call ratio
- 89%
- Price per share
- $25.17
- Number of holders
- 113
- Value change
- -$50,104,402
- Number of buys
- 53
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 76155X100?
CUSIP 76155X100 identifies RVMD - Revolution Medicines, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76155X100:
Top shareholders of RVMD - Revolution Medicines, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4%
|
7,797,884
|
$214,521,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
6,240,198
|
$171,668,000 | — | 30 Sep 2021 | |
| TRV GP III, LLC |
13F
|
Company |
2.9%
|
5,524,031
|
$151,966,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.6%
|
5,106,038
|
$140,466,000 | — | 30 Sep 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.4%
|
4,537,102
|
$124,815,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.8%
|
3,484,264
|
$95,852,000 | — | 30 Sep 2021 | |
| Bellevue Group AG |
13F
|
Company |
1.8%
|
3,458,805
|
$95,152,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.6%
|
3,144,700
|
$86,511,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
2,809,172
|
$77,280,000 | — | 30 Sep 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
1.5%
|
2,800,000
|
$77,028,000 | — | 30 Sep 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.4%
|
2,750,000
|
$75,653,000 | — | 30 Sep 2021 | |
| BVF INC/IL |
13F
|
Company |
1.3%
|
2,485,049
|
$68,364,000 | — | 30 Sep 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.81%
|
1,565,712
|
$43,073,000 | — | 30 Sep 2021 | |
| TRV GP IV, LLC |
13F
|
Company |
0.74%
|
1,419,900
|
$39,061,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.68%
|
1,318,644
|
$36,277,000 | — | 30 Sep 2021 | |
| Capital World Investors |
13F
|
Company |
0.64%
|
1,228,000
|
$33,782,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
1,080,939
|
$29,736,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.53%
|
1,019,846
|
$28,056,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
973,898
|
$26,792,000 | — | 30 Sep 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.5%
|
959,227
|
$26,393,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.45%
|
869,484
|
$23,920,000 | — | 30 Sep 2021 | |
| Ponoi II Management, LLC |
13F
|
Company |
0.35%
|
685,011
|
$18,845,000 | — | 30 Sep 2021 | |
| Ponoi Management, LLC |
13F
|
Company |
0.35%
|
685,011
|
$18,845,000 | — | 30 Sep 2021 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.35%
|
670,382
|
$18,442,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
559,668
|
$15,396,000 | — | 30 Sep 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.25%
|
489,364
|
$13,462,000 | — | 30 Sep 2021 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.23%
|
438,054
|
$12,051,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
425,840
|
$11,715,000 | — | 30 Sep 2021 | |
| NORGES BANK |
13F
|
Company |
0.21%
|
405,966
|
$11,168,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.18%
|
342,275
|
$9,416,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
268,215
|
$7,379,000 | — | 30 Sep 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.12%
|
226,228
|
$6,224,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.12%
|
222,222
|
$6,113,000 | — | 30 Sep 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.11%
|
209,731
|
$5,770,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
186,971
|
$5,144,000 | — | 30 Sep 2021 | |
| MPM BioImpact LLC |
13F
|
Company |
0.08%
|
150,000
|
$4,127,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
117,350
|
$3,228,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
113,434
|
$3,121,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
105,500
|
$2,902,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
99,982
|
$2,750,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.05%
|
99,276
|
$2,731,000 | — | 30 Sep 2021 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
0.05%
|
99,104
|
$2,726,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
93,422
|
$2,570,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
89,356
|
$2,459,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
86,100
|
$2,369,000 | — | 30 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
80,810
|
$2,223,000 | — | 30 Sep 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
76,800
|
$2,113,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
73,294
|
$2,016,000 | — | 30 Sep 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
73,000
|
$2,008,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
72,446
|
$1,993,000 | — | 30 Sep 2021 |
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2021
As of 31 Dec 2021,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,332,089 shares.
The largest 10 holders included
VANGUARD GROUP INC, FMR LLC, TRV GP III, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, BOXER CAPITAL, LLC, Bellevue Group AG, Column Group LLC, Nextech Invest AG, and Woodline Partners LP.
This page lists
113
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
109
Q4 2021 holders
113
Holder diff
4
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.